Thank you for referring your patient with lymphoma or another related blood disorder to the Weill Cornell Lymphoma Program. We pride ourselves on providing the best possible care for patients and are happy to provide services in the following areas:
- New patient referrals We welcome all new patient referrals. An attending physician from the Lymphoma Program will discuss the case in detail with you and will be happy to collaborate in the care of your patients. Please call (646) 962-9340 and inform the staff that you are a physician referring a patient.
- Second opinions We would be happy to work closely with you to provide up-to-date care and advice for your patients with lymphoma and other related blood disorders. We can communicate with you via email or phone.
- Clinical trials Our treatment of lymphoma patients has a substantial focus on therapy through clinical trials. We have contributed to the development of the majority of recently FDA-approved lymphoid cancer therapies and are continually conducting trials with the most promising novel agents. Please browse our clinical trial offerings to see, if any current studies would benefit your patients with Hodgkin lymphoma or non-Hodgkin lymphoma such as DLBCL, follicular lymphoma, mantle cell lymphoma, T-cell lymphomas, CLL/SLL, and Waldenstrom’s Macroglobulinemia.
Finally, we encourage you to sign up for the Lymphoma Program Provider Newsletter, using the form in the right column, to receive announcements of newly launched clinical trials. You may unsubscribe at any time. We do not share our newsletter subscriber list with any other organization, nor do we sell the list to any marketing companies. If you have any questions regarding the referring providers’ newsletter, please call (646) 962-2074 or click here to email us.